Fundraising Fox
/People
Sign in

Dongxing Zha

Investor

Founder / EIR at 82VS

Houston, Texas, United States

Find your path to Dongxing

163 people in our graph can introduce you to Dongxing.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Mary McCarthy to introduce you to Dongxing

You →Mary · together at Max-Planck-Institut für Kohlenforschung (2001–2002) →Dongxing

Ask Jamie Chen to introduce you to Dongxing

You →Jamie · 4 people · together at GlycoFi →Dongxing

Ask Sam Okafor to introduce you to Dongxing

You →Sam · together at Chinese Academy Of Sciences →Dongxing

Sign up to find every way you can get introduced to Dongxing

  • Your email: the people you already email who know Dongxing
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Dongxing
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Dongxing Zha is founder and CEO of Keyway TCR Discovery and co-founder and CEO of Ypsilon Therapeutics, companies focused on TCR-based and TCRm therapeutics for cancer. He has over two decades of experience in immuno-oncology and biologics research and development, with prior scientific leadership roles at MD Anderson Cancer Center and Merck Research Laboratories, where he led discovery programs in bispecifics, TCRs, and cell therapy.

Experience

  1. Ypsilon TherapeuticsDirector Board of Directorscurrent2022 — present
  2. Ypsilon TherapeuticsFounder and CEOcurrent2022 — presentHouston, Texas
  3. Alloy Therapeutics, Inc.CTO, TCR Discovery and Engineering at Alloy Therapeutics | Founder and CEO at Keyway TCR Discovery2021 — 2025Boston, Massachusetts, United States
  4. MD Anderson Cancer CenterInstitute Head, ORBIT Platform2019 — 2021Greater Houston
  5. MD Anderson Cancer CenterInstitute Associate Director2017 — 2019Greater Houston
  6. MD Anderson Cancer CenterInstitute Group Leader2014 — 2017Greater Houston
  7. MerckResearch Fellow and Group Leader2006 — 2014
  8. GlycoFiSenior Research Scientist2002 — 2006Lebanon, NH
  9. Max-Planck-Institut für KohlenforschungPostdoctoral Fellow1999 — 2002
  10. Novo NordiskResearch Scientist1998 — 1999
  11. Chinese Academy of SciencesScientist1997 — 1998

Skills & more

Oncology3Pharmaceutics2Drug Discovery32Monoclonal Antibodies18Antibodies34Protein Engineering11yeast surface displayDirected evolutionPreclinical studies1Autoimmune DiseasesSystemic lupus erythematosusPhage display
+12 moreBispecific antibodiesStandard Molecular BiologyB-cell biologyImmunomodulatoryGlycobiologyProtein expression and yield improvementError-prone PCRDNA library constructionBiomarkersDrug DevelopmentAssay DevelopmentBiochemistry

From Dongxing's professional profile.

Colleagues at 82VS

Andrei Ramirez-Valdez
Venture Associate at 82VS
Andrew Peterson
Founder / EIR at 82VS
Arthur Suckow
Investor at 82VS
Caitlin Tolman
Chief Operating Officer at 82VS
Colby Jordan
Vice President, Capital Formation at 82VS
Errik Anderson
Board Director at Basecamp Fund
Hemanta Baruah
Founder / EIR at 82VS
June Almenoff
Investor at 82VS

Frequently asked questions

Who is Dongxing Zha?
Dongxing Zha is founder and CEO of Keyway TCR Discovery and co-founder and CEO of Ypsilon Therapeutics, companies focused on TCR-based and TCRm therapeutics for cancer. He has over two decades of experience in immuno-oncology and biologics research and development, with prior scientific leadership roles at MD Anderson Cancer Center and Merck Research Laboratories, where he led discovery programs in bispecifics, TCRs, and cell therapy.
Where does Dongxing Zha work?
Dongxing Zha is Founder / EIR at 82VS.
Where did Dongxing Zha go to school?
Dongxing Zha studied at Huazhong Agricultural University (Doctor of Philosophy - PhD, Microbiology, General).

Shared employers